These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 32493087

  • 21. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhang M, Chen CY, Hu Y, Lyu B.
    Zhonghua Nei Ke Za Zhi; 2020 Jan 01; 59(1):40-46. PubMed ID: 31887835
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.
    Luo Y, Feng C, Wu J, Wu Y, Liu D, Wu J, Dai F, Zhang J.
    Dig Dis Sci; 2016 Oct 01; 61(10):2878-2886. PubMed ID: 27250983
    [Abstract] [Full Text] [Related]

  • 25. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
    Willot S, Gauthier C, Patey N, Faure C.
    Neurogastroenterol Motil; 2012 Aug 01; 24(8):734-9, e347. PubMed ID: 22625872
    [Abstract] [Full Text] [Related]

  • 26. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
    Hasler WL, Grabauskas G, Singh P, Owyang C.
    Neurogastroenterol Motil; 2022 Jul 01; 34(7):e14339. PubMed ID: 35315179
    [Abstract] [Full Text] [Related]

  • 27. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study.
    Xiao WB, Liu YL.
    Dig Dis Sci; 2004 Feb 01; 49(2):312-9. PubMed ID: 15104377
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Close association between abnormal expressed enzymes of energy metabolism and diarrhea-predominant irritable bowel syndrome.
    Zhang CY, Yao X, Sun G, Yang YS.
    Chin Med J (Engl); 2019 Jan 20; 132(2):135-144. PubMed ID: 30614852
    [Abstract] [Full Text] [Related]

  • 32. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.
    Zhou Q, Zhang B, Verne GN.
    Pain; 2009 Nov 20; 146(1-2):41-6. PubMed ID: 19595511
    [Abstract] [Full Text] [Related]

  • 33. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP, Nandasiri SD, Hewavisenthi J, Manamperi A, Ariyasinghe MP, Dassanayake AS, Jewell DP, de Silva HJ.
    Scand J Gastroenterol; 2012 Jun 20; 47(6):619-24. PubMed ID: 22486731
    [Abstract] [Full Text] [Related]

  • 34. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
    Martínez C, Rodiño-Janeiro BK, Lobo B, Stanifer ML, Klaus B, Granzow M, González-Castro AM, Salvo-Romero E, Alonso-Cotoner C, Pigrau M, Roeth R, Rappold G, Huber W, González-Silos R, Lorenzo J, de Torres I, Azpiroz F, Boulant S, Vicario M, Niesler B, Santos J.
    Gut; 2017 Sep 20; 66(9):1537-1538. PubMed ID: 28082316
    [Abstract] [Full Text] [Related]

  • 35. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sánchez A, Guilarte M, Antolín M, de Torres I, González-Castro AM, Pigrau M, Saperas E, Azpiroz F, Santos J.
    Am J Gastroenterol; 2012 May 20; 107(5):736-46. PubMed ID: 22415197
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR.
    Gut; 2007 Feb 20; 56(2):203-9. PubMed ID: 17005763
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome].
    Wang XM, Liu YL.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3415-7. PubMed ID: 19159572
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.